Financials
- Market Capitalization 1.83 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-25.35
ratio cours/chiffre d'affaires
26.85
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2037 | VIR Vir Biotechnology, Inc. - Common Stock | 10.92 USD | -3.45% | +12.46% | +23.53% | +82.61% | 1.85 B USD | ||
| 2047 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.75 USD | -3.52% | -4.96% | +6.28% | +102.46% | 1.87 B USD | ||
| 2054 | IMCR Immunocore Holdings plc - American Depositary Shares | 36.38 USD | -1.01% | -1.14% | +8.89% | +8.66% | 1.87 B USD | ||
| 2059 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.81 USD | -2.29% | -0.70% | +18.94% | -6.63% | 1.80 B USD |